A Study to Evaluate Safety and Efficacy of PBK_M2502
NCT07114406
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Intestinal Disease
Colonic Diseases
Gastrointestinal Disease
Digestive System Disease
Interventions
DRUG:
PBK_M2502 1-Day
DRUG:
PBK_M2502 2-Day
Sponsor
Pharmbio Korea Co., Ltd.